Nuwellis announces NIH awarded $3M multi-year grant to KBT

Nuwellis (NUWE) announced that the National Institutes of Health, NIH, has awarded an approximately $3 million multi-year grant to its development partner, Koronis Biomedical Technologies Corporation, KBT. The NIH-supported program will accelerate Vivian, Nuwellis’ dedicated pediatric continuous renal replacement therapy, CRRT, device in development for patients under 20 kilograms, and advance core software and firmware that strengthen the company’s broader portfolio. “Every conversation with a pediatric ICU team brings us back to the same truth – families need options that were built for their child, not borrowed from adult care,” said John Erb, Chief Executive Officer of Nuwellis. “This grant helps us finish critical software and firmware development, run the initial investigational study, and move Vivian toward commercial readiness. Just as important, the technology we’re building for these kids strengthens our entire platform and opens real avenues for growth for Nuwellis.”